Select Medical Holdings Corp expected to post earnings of 61 cents a share - Earnings Preview

Select Medical Holdings

31/07/2024 24:41

* Select Medical Holdings Corp  SEM.N   SEM  is expected
to show a
rise in quarterly revenue when it reports  results on August 1
for the period ending June 30 2024
    * The Mechanicsburg Pennsylvania-based  company is expected
to
report a 4.2% increase in revenue to $1.745 billion from $1.67
billion a year ago, according to the mean estimate from 3
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Select Medical Holdings
Corp
is for earnings of 61 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Select
Medical
Holdings Corp is $37.00​, below​ its last closing price
of $39.76. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  0.57        0.58       0.75      Beat    30.4
 Dec. 31 2024  0.37        0.36       0.36      Met     1.4
 Sep. 30 2023  0.41        0.41       0.46      Beat    12.9​
 Jun. 30 2023  0.48        0.48       0.61      Beat    27.4
 ​​Jan.        0.41        0.44       0.56      Beat    28.1
 1 0001                                                 
 Dec. 31 2022  0.35        0.36       0.22      Missed  -38.8​
 Sep. 30 2022  0.45        0.45       0.21      Missed  -53.7
 Jun. 30 2022  0.56        0.55       0.43      Missed  -22.2
 This summary was machine generated July 30 at 23:41 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)